angiogenesis

Plummeting blood sugar can accelerate eye damage due to diabetes. Results in mice suggest that a new drug targeting hypoxia inducible factor could help.

Immunologist Gabriel Rabinovich leverages his 30 years of experience studying sugar-binding proteins, galectins, for developing novel therapies.

The discovery of a blood vessel-promoting protein interaction found in all ovarian tumors may lead to a new druggable target for ovarian cancers.